Advocacy and Patient Involvement in Clinical Trials

[1]  L. Collette,et al.  Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials , 2018, Clinical trials.

[2]  T. Rader,et al.  The prevalence of patient engagement in published trials: a systematic review , 2018, Research Involvement and Engagement.

[3]  P. Kluetz,et al.  Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada. , 2018, The Lancet. Oncology.

[4]  J. Kim,et al.  Patient-centered recruitment and retention for a randomized controlled study , 2018, Trials.

[5]  C. Kuehn.  Patient Experience Data in US Food and Drug Administration (FDA) Regulatory Decision Making: A Policy Process Perspective , 2018, Therapeutic innovation & regulatory science.

[6]  L. Minasian,et al.  Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections , 2017, Clinical Cancer Research.

[7]  Alix M B Lacoste,et al.  Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis , 2017, Acta Neuropathologica.

[8]  J. Woodcock,et al.  Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both. , 2017, The New England journal of medicine.

[9]  Larry R Hearld,et al.  Engaging patients as partners in research: Factors associated with awareness, interest, and engagement as research partners , 2017, SAGE open medicine.

[10]  O. Aydin,et al.  Rhino-Orbita-Maxillary Mucormycosis After Liver Transplantation: A Case Report. , 2016, Transplantation proceedings.

[11]  Margaret Anderson,et al.  On the path to a science of patient input , 2016, Science Translational Medicine.

[12]  Ryan Hohman,et al.  Regulatory decision-making meets the real world , 2015, Science Translational Medicine.

[13]  A. Abernethy,et al.  Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey , 2015, PloS one.

[14]  Lisa M. Schwartz,et al.  FDA and the Media: Lessons from Tysabri about Communicating Uncertainty , 2015 .

[15]  J. Donovan,et al.  Professional experiences of accessing cancer drugs in the NHS: the introduction of the Cancer Drugs Fund, the individual versus the population , 2014, BMC Health Services Research.

[16]  Zhiyuan Zheng,et al.  Patient-centeredness in the design of clinical trials. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  M. Tinetti,et al.  Patients' responsibility to participate in decision making and research. , 2013, JAMA.

[18]  E. Vroom.  Is more involvement needed in the clinical trial design & endpoints? , 2012, Orphanet Journal of Rare Diseases.

[19]  V. A. Tallada,et al.  Suppression of the Schizosaccharomyces pombe cut12.1 Cell-Cycle Defect by Mutations in cdc25 and Genes Involved in Transcriptional and Translational Control , 2007, Genetics.

[20]  K. Davis,et al.  A 2020 vision of patient-centered primary care , 2005, Journal of General Internal Medicine.

[21]  Jon D. Miller,et al.  Public attitudes toward participation in cancer clinical trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  D Elbourne,et al.  Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey , 2001, BMJ : British Medical Journal.

[23]  A. Bombak,et al.  A Critical Discussion of Patient Engagement in Research. , 2017, Journal of patient-centered research and reviews.

[24]  A. Bleyer,et al.  The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.